Net Sales: $0.1796M
VistaGen Therapeutics, Inc. [VTGN] posted a loss of $9.76M, marking a rise of 44.17% for this quarter.
Revenue rose to $0.1796M this quarter compared to $-0.89M in the previous quarter.
According to the latest quarterly report the company has filed with the SEC, current earnings were $-9.76M, up 44.17% from $-17.48M.
The company’s net sales for the period were $0.1796M, up 120.12%. Net sales in the previous quarter were $-0.89M.